KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Insulet (PODD) Long-Term Debt Issuances (2011 - 2025)

Insulet posted quarterly Long-Term Debt Issuances of $500000.0 for Q4 2025, up 100.59% year-on-year from $249262.5 in Q4 2024, and down 96.24% on a QoQ basis from $13.3 million in Q3 2025.

Insulet (PODD) has 7 years of Long-Term Debt Issuances data on file, last reported at $500000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances rose 100.59% year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at -$390.8 million (down 180.38% YoY), and the FY2025 full-year result was $49.9 million, up 9.67% from the prior year.
  • Long-Term Debt Issuances for Q4 2025 stood at $500000.0, down from $13.3 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $440.7 million in Q1 2025 and bottomed at -$489.5 million in Q4 2021.
  • The 3-year median for Long-Term Debt Issuances is $500000.0 (2025), against an average of -$56.3 million.
  • Peak annual rise in Long-Term Debt Issuances reached 100.59% in 2025, while the deepest fall reached 89.77% in 2025.
  • A 3-year view of Long-Term Debt Issuances shows it stood at -$489.5 million in 2021, then surged by 82.74% to -$84.5 million in 2024, then jumped by 100.59% to $500000.0 in 2025.
  • The last three Long-Term Debt Issuances figures came in at $500000.0 (Q4 2025), $13.3 million (Q3 2025), and -$404.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 500,000.00
Dec 31, 2025 500,000.00
Sep 30, 2025 13.30 Mn
Sep 30, 2025 13.30 Mn
Jun 30, 2025 -404.60 Mn
Jun 30, 2025 -404.60 Mn
Mar 31, 2025 440.70 Mn
Mar 31, 2025 440.70 Mn
Dec 31, 2024 -84.50 Mn
Dec 31, 2024 -84.50 Mn
Sep 30, 2024 130.00 Mn
Sep 30, 2024 130.00 Mn
Dec 31, 2021 -489.50 Mn
Dec 31, 2021 -489.50 Mn
Dec 31, 2017 391.60 Mn
Dec 31, 2017 391.60 Mn
Dec 31, 2016 -179,000.00
Dec 31, 2016 -179,000.00
Dec 31, 2014 -86,000.00
Dec 31, 2014 -86,000.00
Sep 30, 2014 6,000.00
Sep 30, 2014 6,000.00
Dec 31, 2011 -80,000.00
Dec 31, 2011 -80,000.00
Sep 30, 2011 -74,000.00
Sep 30, 2011 -74,000.00